Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report-Reference-Cited by-同舟云学术

Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report

Published:2008-07 Issue:4 Volume:14 Page:873-875
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

MORFINI M.,LAGUNA P.,LEISSINGER C.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2008.01762.x/fullpdf

Reference24 articles.

1. Physiological basis for transfusion therapy in hemorrhagic disorders: a critical review;Aggeler;Transfusion,1961

2. Intravascular coagulation with use of human prothrombin complex concentrates;Cederbaum;Ann Intern Med,1976

3. Post-Konyne hepatitis: the ineffectiveness of screening for the hepatitis B antigen (HBAg);Sandler;Transfusion,1973

4. Update: Acquired immunodeficiency syndrome (AIDS) among patients with hemophilia United States;CDC: Centers for Disease Control;MMWR Morb Mortal Wkly Rep,1983

5. Viral safety of solvent-detergent treated blood products;Horowitz;Dev Biol Stand,1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The History of Clotting Factor Concentrates Pharmacokinetics;Journal of Clinical Medicine;2017-03-20

2. Pathogenesis and Treatment of Hemophilia;Hematological Disorders in Children;2017

3. Pharmacokinetics of plasma-derived and recombinant factor IX - implications for prophylaxis and on-demand therapy;Haemophilia;2013-06-20

4. Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B;Haemophilia;2013-05-07

5. Managing Hemophilia in Children and Adolescents;SickKids Handbook of Pediatric Thrombosis and Hemostasis;2013